Biocryst Pharmaceuticals reported $1.78M in Ordinary Share Capital for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Adamas Pharmaceuticals ADMS:US 50K 0
Alexion Pharmaceuticals ALXN:US $ 0M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.19M 0.01M
Chemocentryx CCXI:US $ 0.07M 0M
Daiichi Sankyo 4568:JP Y 50000M 0M
GlaxoSmithKline GSK:LN 1347M 1M
Glaxosmithkline GSK:US $ 1347M 1M
Intra Cellular Therapies ITCI:US $ 0.01M 0M
IONIS PHARMACEUT IONS:US $ 0.14M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Mirati Therapeutics MRTX:US $ 0.05M 0M
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Novavax NVAX:US $ 0.75M 0M
Ptc Therapeutics PTCT:US $ 0.07M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Vertex Pharmaceuticals VRTX:US $ 2.59M 0M
YTE INCY:US $ 0.22M 0M
Zogenix ZGNX:US $ 0M 0M